These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29956186)

  • 61. Advances in FIV vaccine technology.
    Uhl EW; Martin M; Coleman JK; Yamamoto JK
    Vet Immunol Immunopathol; 2008 May; 123(1-2):65-80. PubMed ID: 18295907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Altered surface antigen expression on peripheral blood mononuclear cells in cats infected with feline immunodeficiency virus.
    Ohno K; Watari T; Goitsuka R; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1992 Jun; 54(3):517-22. PubMed ID: 1322715
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
    Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
    Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.
    Burkhard MJ; Valenski L; Leavell S; Dean GA; Tompkins WA
    Vaccine; 2002 Dec; 21(3-4):258-68. PubMed ID: 12450701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax
    Westman M; Yang D; Green J; Norris J; Malik R; Parr YA; McDonald M; Hosie MJ; VandeWoude S; Miller C
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancement after feline immunodeficiency virus vaccination.
    Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Westman ME; Malik R; Hall E; Harris M; Norris JM
    Vaccine; 2016 Sep; 34(39):4752-4758. PubMed ID: 27522177
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
    Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Barr FJ; Harbour DA
    Vaccine; 2001 Oct; 20(1-2):49-58. PubMed ID: 11567745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccination against feline immunodeficiency virus using fixed infected cells.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
    Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
    Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
    J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.
    Stevens R; Howard KE; Nordone S; Burkhard M; Dean GA
    J Virol; 2004 Aug; 78(15):8210-8. PubMed ID: 15254192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines.
    Siebelink KH; Tijhaar E; Huisman RC; Huisman W; de Ronde A; Darby IH; Francis MJ; Rimmelzwaan GF; Osterhaus AD
    J Virol; 1995 Jun; 69(6):3704-11. PubMed ID: 7745719
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Feline immunodeficiency virus diagnosis after vaccination.
    Andersen PR; Tyrrell P
    Anim Health Res Rev; 2004 Dec; 5(2):327-30. PubMed ID: 15984349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Perspectives on FIV vaccine development.
    Elyar JS; Tellier MC; Soos JM; Yamamoto JK
    Vaccine; 1997; 15(12-13):1437-44. PubMed ID: 9302758
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
    Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
    AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
    Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
    J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.